Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality

IMPORTANCE: It has been hypothesized that angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) may make patients more susceptible to coronavirus disease 2019 (COVID-19) and to worse outcomes through upregulation of the functional receptor of the virus, angiotensin-co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA
Main Authors: Fosbøl, Emil L., Butt, Jawad H., Østergaard, Lauge, Andersson, Charlotte, Selmer, Christian, Kragholm, Kristian, Schou, Morten, Phelps, Matthew, Gislason, Gunnar H., Gerds, Thomas A., Torp-Pedersen, Christian, Køber, Lars
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2020
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7305566/
https://ncbi.nlm.nih.gov/pubmed/32558877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2020.11301
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados